Abstract
In the United States and many other Western, industrialized countries, lung cancer is one of the most common cancers and the leading cause of cancer death in both men and women. For women, this is a relatively new phenomenon dating back to the late 1980s, while for men it has been so for decades. The incidence in men (presently about 70 per 100,000 men) is falling and has been for some time, while the incidence in women is rapidly rising. This is believed to reflect the fact that women took up the habit of smoking some decades later than men and seem to give up smoking to a lesser extent than men. The prognosis for patients with lung cancer is invariably very poor, as only 13% of patients with the diagnosis will survive 5 years.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Neymark, N. (1998). Lung Cancer. In: Assessing the Economic Value of Anticancer Therapies. Recent Results in Cancer Research, vol 148. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72123-6_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-72123-6_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-72125-0
Online ISBN: 978-3-642-72123-6
eBook Packages: Springer Book Archive